Japan — Vitamins, Minerals, Proteins, and Unconventional Dietary Specialties for Humans — Herbals-Botanicals

← back to leaderboard

Japan received 8 FDA import refusals in Herbals-Botanicals, part of Vitamins, Minerals, Proteins, and Unconventional Dietary Specialties for Humans between 2023-Q4 and 2026-Q3. Volume peaked at 3 in 2025-Q4, with the trend newly active in the last year. The most-cited issues are suppl gmp, no english, and list ingre. No trade baseline is published for this commodity from Japan, so no per-$1B rate is shown here.

Of these, 0 were hazard refusals and 8 were paperwork refusals.

Exporting from Japan? Get an email when shipments from Japan are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

0 2023-Q4 2023-Q4: 0 1 2024-Q1 2024-Q1: 1 0 2024-Q2 2024-Q2: 0 0 2024-Q3 2024-Q3: 0 0 2024-Q4 2024-Q4: 0 0 2025-Q1 2025-Q1: 0 0 2025-Q2 2025-Q2: 0 0 2025-Q3 2025-Q3: 0 3 2025-Q4 2025-Q4: 3 1 2026-Q1 2026-Q1: 1 2 2026-Q2 2026-Q2: 2 1 2026-Q3 2026-Q3: 1

Recent rejections